Senti Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Senti Biosciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 40% to $2,561,000. Profit margin reached -3628%. Total operating expenses were $95,288,000.
Profit Margin
| 2019 | 85K | -21.15M | -24890.59% |
|---|---|---|---|
| 2020 | 394K | -19.86M | -5041.12% |
| 2021 | 2.29M | -55.33M | -2415.1% |
| 2022 | 4.28M | -45.79M | -1068.39% |
| 2023 | 2.56M | -92.91M | -3628.23% |
SNTI Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 2.56M | 4.28M | 2.29M | 394K | 85K |
Cost of revenue | 5.24M | 3.92M | 3.01M | 15.95M | 14.52M |
Gross profit | -2.68M | 366K | -719K | -15.56M | -14.43M |
Operating exp. | |||||
Research and development | 32.15M | 34.06M | 21.95M | 15.95M | 14.52M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 95.28M | 74.91M | 42.73M | 25.08M | 7.39M |
Operating income | -92.72M | -70.62M | -40.44M | -24.69M | -21.78M |
Other income (expenses), net | 9.32M | 12.41M | -14.87M | 4.83M | 625K |
Income before tax | -83.40M | -58.21M | -55.31M | -19.86M | -21.15M |
Income tax expense | 0 | -12.41M | 11K | 150K | 0 |
Net income | -92.91M | -45.79M | -55.33M | -19.86M | -21.15M |
Earnings per share | |||||
Basic EPS | -16.01 | -1.75 | -19 | -4.55 | -1.56 |
Diluted EPS | -16.01 | -1.75 | -19 | -4.55 | -1.56 |
| Data source | Data source | Data source |